The New Ireland Fund, Inc. Announces Record Date and Payment Date for Quarterly Distribution
September 01, 2015 16:02 ET
|
The New Ireland Fund, Inc.
BOSTON, MA--(Marketwired - Sep 1, 2015) - The New Ireland Fund, Inc. (NYSE: IRL) (the "Fund"), a closed-end fund, today announced that it will pay on September 21, 2015, a distribution of US$0.28343...
The New Ireland Fund, Inc. Monthly Portfolio Update
September 01, 2015 16:02 ET
|
The New Ireland Fund, Inc.
BOSTON, MA--(Marketwired - Sep 1, 2015) - The New Ireland Fund, Inc. (NYSE: IRL) today released an updated Monthly portfolio statement as of August 31, 2015.
...
US Federal Contractor Registration: ImageWork USA LLC Officially Becomes a Registered Government Contractor
September 01, 2015 16:01 ET
|
US Federal Contractor Registration
WHITE PLAINS, NY--(Marketwired - September 01, 2015) - Verified Vendor ImageWork USA LLC (ImageWork) has officially become registered in System for Award Management (SAM) and currently active to...
Bob Evans Reports Fiscal 2016 First-Quarter Results, Raises Fiscal Year 2016 Guidance and Will Pursue $200 Million Sale-Leaseback of Restaurant Properties
September 01, 2015 16:01 ET
|
Bob Evans Farms, Inc.
Q1 2016 net sales total $321.7 million. GAAP net income of $0.19 per diluted share. Non-GAAP net Income(1) of $0.51 per diluted share Company increases fiscal year 2016 non-GAAP...
Criteo to Present at the Deutsche Bank Technology Conference
September 01, 2015 16:01 ET
|
Criteo
NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Criteo S.A. (NASDAQ:CRTO), the performance marketing technology company, today announced that Benoît Fouilland, CFO, will present at the Deutsche Bank...
Flexion Therapeutics Granted Fast Track Status by the FDA for FX006 for Treatment of Osteoarthritis of the Knee
September 01, 2015 16:01 ET
|
Flexion Therapeutics, Inc.
BURLINGTON, Mass., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for...
Intra-Cellular Therapies Announces Publication of Positive Phase 2 Schizophrenia Study in the Journal Biological Psychiatry
September 01, 2015 16:01 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
LifeVantage Announces Fourth Quarter and Full Fiscal Year 2015 Results
September 01, 2015 16:00 ET
|
Lifevantage Corporation
Full Fiscal Year 2015 Revenue Was $190.3 Million Generated $17.4 Million Adjusted EBITDA and $7.0 Million Net Income in Fiscal Year 2015 Company Provides Fiscal 2016 Guidance; Expects to Achieve...
Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
September 01, 2015 16:00 ET
|
Wright Medical Group N.V.
First Clinically Proven, Cost-Effective Alternative to Autograft for Ankle and/or Hindfoot Fusion Indications Company Can Now Initiate Commercial Sale and Distribution of AUGMENT® Bone Graft in the...
Covisint to Speak on Mobility and the Sharing Economy at TU-Automotive's Insurance Telematics USA Conference
September 01, 2015 16:00 ET
|
Covisint Corporation
DETROIT, Sept. 1, 2015 (GLOBE NEWSWIRE) -- Covisint Corporation (Nasdaq:COVS), a leading cloud platform provider enabling Internet of Things (IoT) and Identity Management-centric (IdM) solutions,...